Mcl-1 is a potential therapeutic target in multiple types of cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-12-16

AUTHORS

C. Akgul

ABSTRACT

.Resistance to apoptosis is a common challenge in human malignancies contributing to both progress of cancer and resistance to conventional therapeutics. Abnormalities in a variety of cell intrinsic and extrinsic molecular mechanisms cooperatively promote tumor formation. Therapeutic approaches that specifically target components of these molecular mechanisms are getting widespread attention. Mcl-1 is a highly expressed pro-survival protein in human malignancies and its cellular expression is tightly regulated via multiple mechanisms. Mcl-1 differs from other members of the Bcl-2 family in having a very short half-life. So inhibition of its expression and/or neutralization of its anti-apoptotic function will rapidly make Mcl-1-dependent cells more susceptible to apoptosis and provide an opportunity to combat several types of cancers. This review summarizes the current knowledge on the regulation of Mcl-1 expression and discusses the alternative approaches targeting Mcl-1 in human cancer cells whose survivals mainly depend on Mcl-1. More... »

PAGES

1326-1336

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00018-008-8637-6

DOI

http://dx.doi.org/10.1007/s00018-008-8637-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023498818

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19099185


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis Regulatory Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Delivery Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myeloid Cell Leukemia Sequence 1 Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-bcl-2", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Faculty of Arts and Sciences, Department of Chemistry, Biochemistry Research Group, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100, Canakkale, Turkey", 
          "id": "http://www.grid.ac/institutes/grid.412364.6", 
          "name": [
            "Faculty of Arts and Sciences, Department of Chemistry, Biochemistry Research Group, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100, Canakkale, Turkey"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Akgul", 
        "givenName": "C.", 
        "id": "sg:person.0653076706.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653076706.54"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2008-12-16", 
    "datePublishedReg": "2008-12-16", 
    "description": "Abstract.Resistance to apoptosis is a common challenge in human malignancies contributing to both progress of cancer and resistance to conventional therapeutics. Abnormalities in a variety of cell intrinsic and extrinsic molecular mechanisms cooperatively promote tumor formation. Therapeutic approaches that specifically target components of these molecular mechanisms are getting widespread attention. Mcl-1 is a highly expressed pro-survival protein in human malignancies and its cellular expression is tightly regulated via multiple mechanisms. Mcl-1 differs from other members of the Bcl-2 family in having a very short half-life. So inhibition of its expression and/or neutralization of its anti-apoptotic function will rapidly make Mcl-1-dependent cells more susceptible to apoptosis and provide an opportunity to combat several types of cancers. This review summarizes the current knowledge on the regulation of Mcl-1 expression and discusses the alternative approaches targeting Mcl-1 in human cancer cells whose survivals mainly depend on Mcl-1.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00018-008-8637-6", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1295005", 
        "issn": [
          "1420-682X", 
          "1420-9071"
        ], 
        "name": "Cellular and Molecular Life Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "66"
      }
    ], 
    "keywords": [
      "Mcl-1", 
      "molecular mechanisms", 
      "Bcl-2 family", 
      "anti-apoptotic function", 
      "pro-survival proteins", 
      "extrinsic molecular mechanisms", 
      "human malignancies", 
      "human cancer cells", 
      "Mcl-1 expression", 
      "variety of cells", 
      "potential therapeutic target", 
      "cellular expression", 
      "tumor formation", 
      "cancer cells", 
      "progress of cancer", 
      "types of cancer", 
      "current knowledge", 
      "multiple mechanisms", 
      "therapeutic target", 
      "expression", 
      "apoptosis", 
      "cells", 
      "conventional therapeutics", 
      "therapeutic approaches", 
      "cancer", 
      "mechanism", 
      "malignancy", 
      "protein", 
      "regulation", 
      "multiple types", 
      "family", 
      "resistance", 
      "therapeutics", 
      "inhibition", 
      "members", 
      "target", 
      "abnormalities", 
      "survival", 
      "function", 
      "types", 
      "variety", 
      "formation", 
      "review", 
      "neutralization", 
      "components", 
      "common challenges", 
      "progress", 
      "alternative approach", 
      "knowledge", 
      "approach", 
      "widespread attention", 
      "opportunities", 
      "challenges", 
      "attention"
    ], 
    "name": "Mcl-1 is a potential therapeutic target in multiple types of cancer", 
    "pagination": "1326-1336", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023498818"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00018-008-8637-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19099185"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00018-008-8637-6", 
      "https://app.dimensions.ai/details/publication/pub.1023498818"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_456.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00018-008-8637-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00018-008-8637-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00018-008-8637-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00018-008-8637-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00018-008-8637-6'


 

This table displays all metadata directly associated to this object as RDF triples.

155 TRIPLES      20 PREDICATES      89 URIs      79 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00018-008-8637-6 schema:about N295f909249dd4fd085c06dcc9fb568ad
2 N44752bd20c2f4638b1cfd03b05a86c56
3 N52a65968e92449e6aba6ef10d3a0e85d
4 N538787904fce47398a3d1776b25abab4
5 N5983564b921644d29ec0cebc30e8923e
6 N60a7684ca3054a1db20bc6b71e8def9e
7 N8b63db3bedf448deb8b328532db466c5
8 N9ad704de265547b78497998b1a52fd43
9 anzsrc-for:06
10 anzsrc-for:0601
11 anzsrc-for:11
12 anzsrc-for:1112
13 schema:author Nf96355829f5f4bcdb804266a8e8dfdb8
14 schema:datePublished 2008-12-16
15 schema:datePublishedReg 2008-12-16
16 schema:description Abstract.Resistance to apoptosis is a common challenge in human malignancies contributing to both progress of cancer and resistance to conventional therapeutics. Abnormalities in a variety of cell intrinsic and extrinsic molecular mechanisms cooperatively promote tumor formation. Therapeutic approaches that specifically target components of these molecular mechanisms are getting widespread attention. Mcl-1 is a highly expressed pro-survival protein in human malignancies and its cellular expression is tightly regulated via multiple mechanisms. Mcl-1 differs from other members of the Bcl-2 family in having a very short half-life. So inhibition of its expression and/or neutralization of its anti-apoptotic function will rapidly make Mcl-1-dependent cells more susceptible to apoptosis and provide an opportunity to combat several types of cancers. This review summarizes the current knowledge on the regulation of Mcl-1 expression and discusses the alternative approaches targeting Mcl-1 in human cancer cells whose survivals mainly depend on Mcl-1.
17 schema:genre article
18 schema:isAccessibleForFree false
19 schema:isPartOf N6f65bbcc595048b7a585f17f75de8315
20 N9c61801e6de94132afc983298035acb5
21 sg:journal.1295005
22 schema:keywords Bcl-2 family
23 Mcl-1
24 Mcl-1 expression
25 abnormalities
26 alternative approach
27 anti-apoptotic function
28 apoptosis
29 approach
30 attention
31 cancer
32 cancer cells
33 cells
34 cellular expression
35 challenges
36 common challenges
37 components
38 conventional therapeutics
39 current knowledge
40 expression
41 extrinsic molecular mechanisms
42 family
43 formation
44 function
45 human cancer cells
46 human malignancies
47 inhibition
48 knowledge
49 malignancy
50 mechanism
51 members
52 molecular mechanisms
53 multiple mechanisms
54 multiple types
55 neutralization
56 opportunities
57 potential therapeutic target
58 pro-survival proteins
59 progress
60 progress of cancer
61 protein
62 regulation
63 resistance
64 review
65 survival
66 target
67 therapeutic approaches
68 therapeutic target
69 therapeutics
70 tumor formation
71 types
72 types of cancer
73 variety
74 variety of cells
75 widespread attention
76 schema:name Mcl-1 is a potential therapeutic target in multiple types of cancer
77 schema:pagination 1326-1336
78 schema:productId N0545ae6521fc498ba8929d8161acd459
79 N4b4a79eb516a44cc8c128d4391489df5
80 Nd19e803022cd4f41a293c455329ee443
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023498818
82 https://doi.org/10.1007/s00018-008-8637-6
83 schema:sdDatePublished 2022-08-04T16:57
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N37fe49c906bf48bfbed8f04b05c02ef0
86 schema:url https://doi.org/10.1007/s00018-008-8637-6
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N0545ae6521fc498ba8929d8161acd459 schema:name doi
91 schema:value 10.1007/s00018-008-8637-6
92 rdf:type schema:PropertyValue
93 N295f909249dd4fd085c06dcc9fb568ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Drug Delivery Systems
95 rdf:type schema:DefinedTerm
96 N37fe49c906bf48bfbed8f04b05c02ef0 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N44752bd20c2f4638b1cfd03b05a86c56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Proto-Oncogene Proteins c-bcl-2
100 rdf:type schema:DefinedTerm
101 N4b4a79eb516a44cc8c128d4391489df5 schema:name pubmed_id
102 schema:value 19099185
103 rdf:type schema:PropertyValue
104 N52a65968e92449e6aba6ef10d3a0e85d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Neoplasms
106 rdf:type schema:DefinedTerm
107 N538787904fce47398a3d1776b25abab4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Humans
109 rdf:type schema:DefinedTerm
110 N5983564b921644d29ec0cebc30e8923e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Gene Expression Regulation, Neoplastic
112 rdf:type schema:DefinedTerm
113 N60a7684ca3054a1db20bc6b71e8def9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Neoplasm Proteins
115 rdf:type schema:DefinedTerm
116 N6f65bbcc595048b7a585f17f75de8315 schema:volumeNumber 66
117 rdf:type schema:PublicationVolume
118 N8b63db3bedf448deb8b328532db466c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Apoptosis Regulatory Proteins
120 rdf:type schema:DefinedTerm
121 N9ad704de265547b78497998b1a52fd43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Myeloid Cell Leukemia Sequence 1 Protein
123 rdf:type schema:DefinedTerm
124 N9c61801e6de94132afc983298035acb5 schema:issueNumber 8
125 rdf:type schema:PublicationIssue
126 Nd19e803022cd4f41a293c455329ee443 schema:name dimensions_id
127 schema:value pub.1023498818
128 rdf:type schema:PropertyValue
129 Nf96355829f5f4bcdb804266a8e8dfdb8 rdf:first sg:person.0653076706.54
130 rdf:rest rdf:nil
131 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
132 schema:name Biological Sciences
133 rdf:type schema:DefinedTerm
134 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
135 schema:name Biochemistry and Cell Biology
136 rdf:type schema:DefinedTerm
137 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
138 schema:name Medical and Health Sciences
139 rdf:type schema:DefinedTerm
140 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
141 schema:name Oncology and Carcinogenesis
142 rdf:type schema:DefinedTerm
143 sg:journal.1295005 schema:issn 1420-682X
144 1420-9071
145 schema:name Cellular and Molecular Life Sciences
146 schema:publisher Springer Nature
147 rdf:type schema:Periodical
148 sg:person.0653076706.54 schema:affiliation grid-institutes:grid.412364.6
149 schema:familyName Akgul
150 schema:givenName C.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653076706.54
152 rdf:type schema:Person
153 grid-institutes:grid.412364.6 schema:alternateName Faculty of Arts and Sciences, Department of Chemistry, Biochemistry Research Group, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100, Canakkale, Turkey
154 schema:name Faculty of Arts and Sciences, Department of Chemistry, Biochemistry Research Group, Canakkale Onsekiz Mart University, Terzioglu Campus, 17100, Canakkale, Turkey
155 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...